TY  - GEN
AU  - Ruggeri,M
AU  - Rolli,F R
AU  - Kondili,L A
AU  - Drago,C
AU  - De Solda,F
AU  - Nappi,C
AU  - Cicchetti,A
TI  - Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy
SN  - 1744-8379
PY  - 2019///0502
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Benzimidazoles
KW  - Carbamates
KW  - Cohort Studies
KW  - Cost-Benefit Analysis
KW  - Drug Therapy, Combination
KW  - Fluorenes
KW  - Genotype
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Imidazoles
KW  - Italy
KW  - Markov Chains
KW  - Pyrrolidines
KW  - Quality-Adjusted Life Years
KW  - Ribavirin
KW  - Simeprevir
KW  - Sofosbuvir
KW  - Uridine Monophosphate
KW  - Valine
KW  - analogs & derivatives
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1080/14737167.2019.1537784
ER  -